Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services tags : N::A save search
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DH | $7.28 -0.68% -0.69% 730K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
first conference financial results
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
SEER | $1.81 8.38% 7.73% 1.5M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
first report financial results
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DAWN S | $16.65 8.26% 7.63% 6.6M
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
day fda approval tumor for
iCoreConnect Inc. Announces New State Endorsement of Seven Solutions From the Tennessee Dental Association
Published: 2024-04-23 (Crawled : 18:00) - globenewswire.com
ICCT | $1.09 -2.68% -3.7% 140K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
endorsement association state dental solutions
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
WGS | $12.045 15.93% 13.74% 250K
|
Professional, Scientific, and T...
|
| O: 4.71%
H: 22.87%
C: 17.3%
partnership rare disease health
Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
HOWL | $6.41 5.26% 4.99% 390K
|
Professional, Scientific, and T...
|
| O: 2.17%
H: 5.06%
C: 5.06%
il-10 first disease preclinical for meeting therapeutics potential therapy
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
IPSC | $3.13 2.62% 2.56% 75K
|
Professional, Scientific, and T...
|
| O: 0.98%
H: 15.21%
C: 1.29%
genetic cell therapeutics therapy
First Advantage Releases 2024 Global Trends Report
Published: 2024-04-23 (Crawled : 10:00) - globenewswire.com
FA | $16.42 5.94% 5.6% 980K
|
Professional, Scientific, and T...
|
| O: 3.07%
H: 5.77%
C: 4.06%
first report advantage global trends
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
TCRX | News 3 d | $7.23 1.55% 1.52% 210K
|
Professional, Scientific, and T...
|
| O: 1.4%
H: 4.57%
C: 0.55%
cell meeting therapeutics therapy
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
AKYA | News | $3.82 -2.05% -2.09% 86K
|
Professional, Scientific, and T...
|
| O: -0.51%
H: 3.09%
C: -1.8%
first report financial results
Lignocellulosic Feedstock-based Biofuel Market size is set to grow by USD 1.4 billion from 2023-2027, Aemetis Inc., ALTRET GREENFUELS Ltd and BDI BioEnergy International GmbH, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-19 (Crawled : 23:00) - prnewswire.com
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
| Email alert
Add to watchlist
IKTSF | $62.15 -16.86% 320
|
Commercial Services
| Email alert
Add to watchlist
IKTSY | $61.83 -12.21% 2.5K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
international set key market
Life Science Cares Launches in Switzerland
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
MOLN | $3.88 -3.54% 520
|
Professional, Scientific, and T...
|
| O: 0.82%
H: 2.72%
C: -9.54%
life cares switzerland
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
VERV | $6.88 -0.43% -0.44% 960K
|
Professional, Scientific, and T...
|
| O: -2.23%
H: 3.19%
C: 0.76%
for potential
IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
DOCS | $24.58 -0.85% 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: -0.96%
H: 1.41%
C: -0.69%
PERI | $11.33 4.23% 4.06% 790K
|
Technology Services
|
| O: -3.28%
H: 0.27%
C: -1.88%
TScan Therapeutics Announces Closing of Upsized Public Offering
Published: 2024-04-19 (Crawled : 14:00) - globenewswire.com
TCRX | News 3 d | $7.23 1.55% 1.52% 210K
|
Professional, Scientific, and T...
|
| O: 1.04%
H: 4.55%
C: 0.0%
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.13%
H: 0.0%
C: 0.0%
offering therapeutics
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-18 (Crawled : 00:00) - prnewswire.com
DOCS | $24.58 -0.85% 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: -0.96%
H: 1.41%
C: -0.69%
PERI | $11.33 4.23% 4.06% 790K
|
Technology Services
|
| O: -3.28%
H: 0.27%
C: -1.88%
OMNIQ ANNOUNCES THE LAUNCH OF SEEQ: INNOVATIVE CUSTOMER SITE & DEVICE MANAGEMENT SOFTWARE APP, FOR ENHANCED OPERATIONAL EFFICIENCY OF ITS AI MACHINE VISION SOLUTION
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
OMQS | $0.4201 -0.36% -0.36% 84K
|
Professional, Scientific, and T...
|
| O: 2.0%
H: 0.0%
C: 0.0%
management device solution software vision for
First Advantage to Release First Quarter 2024 Financial Results and Hold Investor Conference Call on May 9, 2024
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
FA | $16.42 5.94% 5.6% 980K
|
Professional, Scientific, and T...
|
| O: -1.1%
H: 0.0%
C: 0.0%
first conference advantage financial results
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
Published: 2024-04-17 (Crawled : 15:00) - globenewswire.com
MOLN | $3.88 -3.54% 520
|
Professional, Scientific, and T...
|
| O: -4.09%
H: 1.33%
C: 1.33%
approved meeting molecular
OMNIQ’s SELF-SERVICE INTERACTIVE CONSUMER MANAGEMENT KIOSKS FEATURED BY ISRAEL’S LARGEST ENERGY COMPANY
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
OMQS | $0.4201 -0.36% -0.36% 84K
|
Professional, Scientific, and T...
|
| O: 15.11%
H: 18.75%
C: -3.13%
management energy company
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.